· |
Chinese and foreign pharmaceutical companies joined forces targeting the generics market |
· |
Who's new drugs: a breakthrough innovation stakes |
· |
Established brand-name drugs face patent "cliff" |
· |
Lipitor will be transferred to OTC |
· |
Pfizer with Daiichi Sankyo to develop the China market of high blood pressure |
· |
Biomedical technology to be poured of cold water |
· |
AstraZeneca announced its latest research rosuvastatin results |